SUSQUEHANNA INTERNATIONAL GROUP, LLP - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 143 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$18,141,000
+220.4%
961,824
+99.9%
0.01%
Q2 2019$5,662,000
+990.9%
481,090
+1166.0%
0.00%
Q1 2019$519,000
+105.1%
38,000
+53.7%
0.00%
Q4 2018$253,000
-67.6%
24,728
-47.3%
0.00%
Q3 2018$781,000
-86.7%
46,900
-87.3%
0.00%
-100.0%
Q2 2018$5,853,000
+29.1%
370,471
+3.8%
0.00%
+100.0%
Q1 2018$4,532,000
+156.8%
356,898
+131.5%
0.00%
Q4 2017$1,765,000
-25.4%
154,190
-20.1%
0.00%
Q3 2017$2,365,000
+83.6%
193,056
+71.6%
0.00%
-100.0%
Q2 2017$1,288,000
-20.0%
112,500
+45.3%
0.00%
Q1 2017$1,609,000
+3.5%
77,400
+3.6%
0.00%
Q4 2016$1,554,000
-37.4%
74,724
-1.3%
0.00%
-100.0%
Q3 2016$2,481,000
-41.5%
75,700
-55.4%
0.00%0.0%
Q2 2016$4,238,000
+42.3%
169,700
+39.6%
0.00%
+100.0%
Q1 2016$2,978,000
-38.2%
121,600
-16.7%
0.00%
-66.7%
Q4 2015$4,821,000
-56.9%
145,977
-57.3%
0.00%
-25.0%
Q3 2015$11,193,000
+16.8%
341,683
+88.8%
0.00%0.0%
Q2 2015$9,587,000
+1095.4%
180,987
+551.5%
0.00%
Q1 2015$802,000
+254.9%
27,781
+146.9%
0.00%
Q2 2014$226,00011,2510.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,628,328$33,869,00014.72%
Foresite Capital Management II, LLC 995,396$20,704,00010.39%
Cormorant Asset Management, LP 1,581,604$32,897,0004.43%
DAFNA Capital Management LLC 221,013$4,597,0004.04%
New Leaf Venture Partners, L.L.C. 228,428$4,751,0003.40%
Partner Investment Management, L.P. 63,571$1,322,0001.75%
Iguana Healthcare Management, LLC 140,000$2,912,0001.74%
PFM Health Sciences, LP 2,913,951$60,610,0001.71%
Redmile Group, LLC 920,550$19,147,0001.65%
SECTORAL ASSET MANAGEMENT INC 669,351$13,923,0001.54%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders